About Medpace
Medpace is a company based in Cincinnati (United States) founded in 1992 was acquired by Cinven in February 2014. The company has 5,900 employees as of December 31, 2024. Medpace has completed 2 acquisitions, including MediTech and Symbios Clinical. Medpace offers products and services including CRO Services, Central Labs, and Bioanalytical Labs. Medpace operates in a competitive market with competitors including Lambda Therapeutic, Dhiti Life Sciences, Ascada Research, JCCT and Diacrin, among others.
- Headquarter Cincinnati, United States
- Employees 5900 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medpace Holdings, Inc.
-
Annual Revenue
$2.11 B (USD)11.84as on Dec 31, 2024
-
Net Profit
$404.34 M (USD)43.07as on Dec 31, 2024
-
EBITDA
$476.12 M (USD)31.11as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
5900
as on Dec 31, 2024
-
Investments & Acquisitions
MediTech
& 1 more
-
Acquired by
Cinven
(Feb 24, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medpace
Medpace is a publicly listed company on the NASDAQ with ticker symbol MEDP in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medpace
Medpace offers a comprehensive portfolio of products and services, including CRO Services, Central Labs, and Bioanalytical Labs.
Manages end-to-end clinical trials for biotechs and sponsors.
Provides biomarker and safety testing for clinical research.
Conducts assays for drug development and preclinical studies.
People of Medpace
Unlock access to complete
Software Development Team
140 people
Leadership Team
127 people
Clinical Team
107 people
Senior Team
54 people
Data Analysis and Operations Team
38 people
Operations Team
28 people
Sales and Marketing
25 people
Regulatory Team
19 people
Unlock access to complete
Funding Insights of Medpace
Investors in Medpace
Medpace has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cinven.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments and portfolio management services are provided by Cinven across various sectors.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Medpace
Medpace has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include MediTech and Symbios Clinical.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical and regulatory consulting services are provided by MediTech.
|
2017 | ||||
|
Full-service clinical research for medical devices is offered.
|
2006 |
Financial Statements - Medpace
Medpace Comparisons
Competitors of Medpace
Medpace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lambda Therapeutic, Dhiti Life Sciences, Ascada Research, JCCT and Diacrin, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CRO with operations in India, US, Poland, Canada and UK. Winner of Frost & Sullivan 'CRO of the Year' - 2010
|
|
| domain | founded_year | HQ Location |
Biotechnology company offering in vitro diagnostic products for healthcare sector
|
|
| domain | founded_year | HQ Location |
Performs clinical research trials to evaluate investigational drugs and devices.
|
|
| domain | founded_year | HQ Location |
CRO focused on early & end stage clinical trial services
|
|
| domain | founded_year | HQ Location |
Educational programs are provided by Diacrin since 1989.
|
Frequently Asked Questions about Medpace
Medpace was founded in 1992.
Medpace is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
August Troendle is the current CEO of Medpace.
As of Dec 31, 2024, the latest employee count at Medpace is 5,900.
Annual revenue of Medpace is $2.11B as on Dec 31, 2024.
Medpace was founded in 1992 and is headquartered in Cincinnati, United States. Services as a clinical research organization are provided, encompassing various aspects of drug development and trial management. Operations are based in the healthcare sector, with focus on full-service support for pharmaceutical clients. Leadership is provided by August Troendle as CEO and President, and the domain medpace.com is utilized for online presence.
Medpace's top competitors include Lambda Therapeutic, Dhiti Life Sciences and JCCT.
Medpace offers CRO Services, Central Labs, and Bioanalytical Labs.
Yes, Medpace is publicly traded on NASDAQ under the ticker symbol MEDP.
Medpace has made 2 acquisitions, including MediTech, and Symbios Clinical.
Medpace has 1 investor. Key investors include Cinven.
The ticker symbol of Medpace is MEDP on NASDAQ.